Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0. This indicates a behind-the-scenes maintenance release rather than a visible change to the content or layout.
    Difference
    0.0%
    Check dated 2026-09-15T21:47:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, indicating a newer version of the page. This update reflects an updated page revision without altering the study data.
    Difference
    0.0%
    Check dated 2026-09-01T18:10:49.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH funding line, '2018 ( U.S. NIH Grant/Contract )', was added to the funding information section, signaling NIH support for the LEAP-004 trial. This provides background on the source of funding for the study.
    Difference
    0.0%
    Check dated 2026-08-25T19:34:15.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a page revision and does not affect the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T17:59:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-07-28T14:41:12.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The revision label in the study documents section was updated from v3.6.0 to v3.6.3, indicating a newer version of the protocol/document referenced on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:08:42.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.